loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 222b630b 7e09 43b4 9894 3d87f10add91 Applno 20496 Form Tablet Oral Dosage 2mg - Drug Product Composition: Glemax

    Menu

    Glemax

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 775Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20496 / DOSAGE - TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GLIMEPIRIDE(UNII: 6KY687524K)
    (GLIMEPIRIDE - UNII:6KY687524K)     		GLIMEPIRIDE4mg | 2mg | 1mg

    Inactive Ingredients

    Ingredient Name
    Sanofi-Aventis U.S. LLC
    ALUMINUM OXIDE(LMI26O6933)
    FD&C BLUE NO. 2(L06K8R7DQK)
    FERRIC OXIDE RED(1K09F3G675)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    POVIDONE, UNSPECIFIED(FZ989GH94E)
    SODIUM STARCH GLYCOLATE TYPE A CORN(AG9B65PV6B)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.